What is Entia?
Founded in 2015, Entia operates at the intersection of healthcare and advanced engineering, focusing on the development of portable, high-precision blood testing solutions. The company addresses a critical market gap by enabling decentralized diagnostic capabilities, thereby reducing the reliance on centralized laboratory infrastructure. As a key innovator in the medical technology space, Entia is currently scaling its enterprise-level operations to meet the increasing demand for remote patient monitoring and point-of-care testing. Its market position is bolstered by a commitment to clinical accuracy and user-centric design, making it a vital contributor to the evolution of modern healthcare delivery systems.
How much funding has Entia raised?
Entia has raised a total of $33.4M across 3 funding rounds:
Angel/Seed
$1.4M
Unspecified
$12M
Series A
$20M
Angel/Seed (2018): $1.4M with participation from Sussex Place Ventures
Unspecified (2021): $12M led by Sussex Place Ventures, Parkwalk Advisors, and BGF
Series A (2023): $20M supported by BGF
Key Investors in Entia
Sussex Place Ventures
An early-stage venture capital firm associated with the London Business School, specializing in enterprise software and patent-protectable deep technology.
Parkwalk Advisors
A leading investor in university spinouts, providing critical expertise and capital to bridge the gap between academic research and commercial healthtech success.
BGF
A highly influential UK-based investor focused on supporting the growth of small and mid-sized businesses across diverse economic sectors.
What's next for Entia?
With the successful closure of this latest financing round, Entia is poised to transition into a phase of rapid commercial expansion and product diversification. The strategic focus will likely center on scaling manufacturing capabilities and expanding its reach within the broader European healthtech market. By utilizing the backing from institutional investors, the company aims to solidify its market leadership, enhance its patent-protected deep technology portfolio, and continue its mission of improving patient outcomes through accessible, high-quality diagnostic data. Future milestones will likely involve deeper integration into clinical workflows and the pursuit of further regulatory approvals to support its long-term growth objectives.
See full Entia company page
